Effects of asparagine synthetase inhibitors on asparaginase resistant tumors.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001215:Asparaginase / Q000494:pharmacology*; D001216:Asparagine / Q000031:analogs & derivatives / Q000378:metabolism / Q000494:pharmacology; D001217:Aspartate-Ammonia Ligase / Q000037:antagonists & inhibitors*; D002460:Cell Line; D003470:Culture Media; D004351:Drug Resistance; D004885:Erwinia / Q000201:enzymology; D004926:Escherichia coli / Q000201:enzymology; D066298:In Vitro Techniques; D007700:Kinetics; D007942:Leukemia, Experimental / Q000188:drug therapy* / Q000201:enzymology / Q000503:physiopathology; D008025:Ligases / Q000037:antagonists & inhibitors*; D051379:Mice
D000970:Antineoplastic Agents; D003470:Culture Media; D001216:Asparagine; D001215:Asparaginase; D008025:Ligases; D001217:Aspartate-Ammonia Ligase